Biological & Neural Integrity / Neurotechnology and BCI
SUB-T05-002Invasive Brain–Computer Interfaces
Definition
Invasive Brain–Computer Interfaces examines clinical benefit, surgical burden, device longevity and explant or replacement pathways for implanted BCIs within the broader domain of the design, validation and long-term use of brain–computer interfaces and neurotechnologies.
Why this matters
Failures concerning clinical benefit, surgical burden, device longevity and explant or replacement pathways for implanted BCIs can cause physical or psychological harm, loss of function, privacy invasion, identity compromise, exclusion, coercion or irreversible impact on human agency.
Research questions
Under which conditions can clinical benefit, surgical burden, device longevity and explant or replacement pathways for implanted BCIs be delivered, measured or protected reliably, and how do outcomes vary by person, device, duration, context and governance controls?
Hypotheses
A transparent, safety-bounded and person-centred approach to invasive brain–computer interfaces, combining validated measurement, informed consent, privacy and security controls, human oversight and longitudinal monitoring, will improve benefit–risk outcomes compared with opaque or technology-centred approaches.
Proposed methods
controlled BCI task testing; signal-quality analysis; calibration studies; longitudinal cohort follow-up; usability and accessibility testing; human-factors analysis; adverse-event monitoring; expert and affected-user review; reproducibility testing; methods adapted specifically to Invasive Brain–Computer Interfaces
Stakeholders and beneficiaries
BCI users; patients; clinicians; carers; neuroscientists; rehabilitation specialists; device manufacturers; regulators; accessibility advocates